Objective: Not all overweight and obese individuals appear to be at equal risk of developing metabolic abnormalities. We sought to examine the effect of factors from different stages of life on risk of metabolic abnormalities at age 50 years in overweight and obese adults. Design and subjects: Longitudinal study of all persons born in Newcastle upon Tyne, UK in May and June 1947 and followed to age 50 years when a clinical examination took place and a detailed questionnaire on health and lifestyle was completed. Participants in this study (n ¼ 223) were those defined as being overweight or obese with a body mass index (BMI) greater than or equal to 25 at age 50 years. Subjects were defined as 'metabolically normal' if they had normal lipids, glucose and blood pressure. Results: Lower BMI was the strongest predictor of remaining metabolically normal in both men and women. After adjusting for BMI, lower levels of cigarette smoking and higher levels of physical activity were independently associated with being metabolically normal in men. No other factors were independently associated with being metabolically normal in women. A stronger inverse relationship between BMI and metabolic status was found in men (Odds ratio (OR) per unit increase in BMI ¼ 0.65, 95% confidence intervals (95% CI) 0.52-0.81) than in women (OR ¼ 0.90, 95% CI 0.82-0.99). No association was seen for factors operating in fetal, infant and childhood life. Conclusions: Adult factors made a greater contribution to remaining metabolically normal than birth or childhood factors in this sample of overweight and obese adults. A lower adult BMI appeared to reduce the risk in men and women and lower cigarette smoking and higher level of physical activity also independently reduced the risk in men. Public health policy to reduce the burden of morbidity associated with obesity should continue to encourage weight loss, physical activity and smoking cessation.
Introduction
It is well established that overweight and obesity are associated with an increased risk of cardiovascular disease. 1, 2 The mechanisms through which obesity exerts its effect on cardiovascular disease are incompletely understood, but are believed to be largely through its association with dyslipidaemia, hypertension, glucose intolerance and diabetes. 1, 2 The concept that a syndrome exists that encompasses these abnormalities was firmly established almost 20 years ago, 3 although earlier work had identified the clustering of adverse metabolic outcomes with abdominal obesity. 4 The syndrome first described by Reaven as Syndrome X 3 is now more commonly referred to as the metabolic syndrome. It has been recognized that a group of individuals exist who develop the features of the metabolic syndrome despite being of normal weight. 5, 6 These individuals have been termed 'metabolically overweight normal weight'. However, it is also becoming apparent that not all overweight and obese individuals are at equal risk of developing the metabolic abnormalities that comprise the metabolic syndrome. A substantial minority of individuals appear to remain 'metabolically normal' despite being overweight or obese (i.e. do not develop any of the core features of the metabolic syndrome -raised lipids, glucose or blood pressure) and could be termed 'metabolically normal overweight' (MENO). The risk of adverse health in middle age has been proposed to be 'programmed' by impaired development in utero, 7 although factors operating later in life may also play an important role, 8 possibly in conjunction with fetal programming. The aim of this study was to identify potential determinants of remaining metabolically normal despite being overweight or obese. We sought to examine the effect of birth and childhood factors as well as the established adult risk factors on metabolic parameters in overweight and obese adults using data from the latest follow-up of the Newcastle Thousand Families Study.
Methods

Participants
The Newcastle Thousand Families cohort was established in 1947 when all 1142 children born in May and June of that year, to mothers resident in the city of Newcastle upon Tyne, were recruited. 9 Two-thirds of the participants were followedup until the end of their 15th year (n ¼ 763), with detailed information prospectively collected on their health, growth and social circumstances. 10 A total of 49 children died before age 15 years and 14 families opted out of the study during that time. The main reason for loss to follow-up in childhood was migration. By 1962, 316 of the children from the original cohort had moved away from the city of Newcastle. Participants in the follow-up at age 50 years were members of the original cohort who were either traced through the National Health Service Central Register or contacted the study team in response to media publicity. Between October 1996 and December 1998, self-completion questionnaires on adult health and lifestyle were sent out and study members invited to attend for clinical examination. [10] [11] [12] Ethical approval for this study was obtained from the appropriate Local Research Ethics Committees. All study members participating in this study gave their written consent.
Of the original 1142 study members, 832 (89% of the surviving sample of 932 children whose families remained in Newcastle upon Tyne for at least the first year of the study) were traced at age 50 years. Of these, 574 completed the health and lifestyle questionnaire and 412 study members attended for clinical examination, of whom 369 (160 men and 209 women) were included in this study after removing twins, those with pre-existing and newly diagnosed diabetes and those for whom core data items were missing. Of these, 223 (110 men and 113 women) were classified as being overweight or obese on the basis of body mass index (BMI) (X25) and comprise the sample for this study. The study sample did not differ significantly (P40.05) from the members of the original cohort not included in this analysis in terms of any of the factors around birth, infancy and childhood.
Clinical assessment
Clinical assessments were performed in the morning following an overnight fast. Anthropometric measurements were made according to the protocol of the World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease project. 13 Height was measured without shoes to the nearest 5 mm, with the head positioned so that the eye and the external auditory meatus were level, and weight was measured to the nearest 100 g with the subject lightly clothed. Waist circumference was measured to the nearest centimetre at the midpoint between the lower costal margin and the superior iliac crest, and the hips over the greater trochanters. Waist circumference was measured with the waist unclothed and hip circumference over the subject's underwear. Blood pressure and pulse were measured following the method of the British Hypertension Society with a mercury sphygmomanometer and a 35 cm cuff. Blood pressure and pulse were measured twice after the subject had been seated for at least 20 min after venepuncture. The average systolic (Korotkoff phase I) and diastolic (Korotkoff phase V) blood pressures, based on the mean of the two measurements, were used for analysis.
Participants without diabetes took an oral glucose tolerance test. They drank 75 g of glucose in 388 ml of water, and venous blood was taken after 30, 60 and 120 min. Plasma was separated by centrifugation within an hour (after refrigeration of the sample). Serum insulin levels were measured by an enzyme-linked immunosorbent assay (Dako Ltd, Ely, UK). Plasma glucose concentrations were measured on a Yellow Springs Analyser (YSI Stat Plus 2300; Yellow Springs Instruments, Farnborough, UK). Insulin resistance (HOMA-IR) was estimated using the Homeostasis Model Assessment, based on fasting insulin and glucose. 13 Serum triglycerides were measured by a lipase/glycerol kinase method on a Cobas Bio centrifugal analyser (Roche Products Ltd, Welwyn, UK) using a commercial kit (Sigma Diagnostics, Poole, UK) (interassay coefficient of variation 1.3%). Serum HDL cholesterol was measured using a cholesterol oxidase method after precipitation of apolipoprotein B containing lipoproteins with phosphotungstic acid and magnesium chloride (interassay coefficient of variation 2.2%).
Definitions
Subjects were defined as being overweight or obese if they had a BMI (weight (kg)/height 2 ) greater than or equal to 25.
'Metabolically normal' was defined as all of the following being present: blood pressure o140/90 mmHg and not on hypertension treatment (self-reported at age 50 years), fasting plasma glucose o6.1 mmol l
À1
, 2-h post 75 g glucose challenge plasma glucose o7.8 mmol l
, HDL cholesterol 40.9/1.0 mmol l À1 (men/women) and fasting triglycerides o1.7 mmol l
Measurement of early life experience
Information on a number of factors, including birth weight, infant feeding, growth and socioeconomic status, was
Metabolically normal overweight adults L Hayes et al recorded prospectively for all study members. Birth weight was recorded at birth and standardized for gestational age and gender.
14 Duration of breastfeeding was extracted from health visitor records. Socioeconomic status (I (the most advantaged) II, III non-manual, III manual, IV and V (the least advantaged)) during childhood was derived prospectively from the contemporary UK Registrar General's Standard Occupational Classification using father's occupation at birth and that of the occupation of the main wage earner in the household at age 5 years. Catch-up growth in childhood was calculated as the difference in z-scores of weight at birth and aged 9 years. Relevant family history was defined as death from cardiovascular disease or clinically diagnosed angina, ischaemic heart disease, stroke or diabetes in a parent or sibling.
Measurement of adult socioeconomic position and lifestyle
Data on adult health and lifestyle were collected by selfadministered questionnaire at age 49-51 years. Occupational details of the main wage earner in the household at age 50 years were coded according to the 1990 UK Registrar General's Standard Occupational Classification and hence social class was derived. Four categories of alcohol consumption at age 50 years were derived. 15 Light drinking was defined as up to 5 units of alcohol per week for women (10 units for men) and moderate drinking up to 21 units for women (28 units for men). The number of pack-years of cigarettes smoked (i.e. one pack-year equals one pack of cigarettes smoked per day for 1 year) was estimated from study members' smoking habits at the ages of 15, 25, 35 and 50 years, as recorded on the self-completion questionnaire at age 50 years. Cross-sectional data, at age 50 years, on total dietary saturated fat intake per day was estimated from responses to the European Prospective Investigation of Cancer and Nutrition food frequency questionnaire, 16 which was included within the questionnaire completed at age 50 years. Level of physical activity at age 50 years was derived from responses to a physical activity questionnaire based on that used in the Medical Research Council's National Survey of Health and Development. 17 Statistical analyses Separate analyses were carried out for men and women. Univariate logistic regression was used to examine the relationship between individual variables and being metabolically normal (no lipid, glucose or blood pressure abnormality) (MENO). Variables found to be significant predictors of being MENO in univariate analysis were then entered into multivariable logistic regression models. Odds ratio (OR) and corresponding 95% confidence intervals (95% CI) are presented.
Results
The prevalence of overweight and obesity in the cohort was 69% in men and 54% in women ( Table 1 ). The following results consider only those study members (110 men and 113 women) classed as overweight or obese at age 50 years. Of these, 36% of men (n ¼ 40) and 42% of women (n ¼ 48) were 'metabolically normal' (Table 1) . In men and women, the metabolically normal (MENO) group did not differ significantly from the group with at least one abnormality (P40.05) on any of the factors that were present at birth or during childhood (Table 2 ). In both men and women, the MENO group had a significantly lower BMI, waist circumference and HOMA-IR than the group with an abnormality. In men, but not women, the MENO group also had a lower waist-to-hip ratio, lower smoking levels and were more physically active than the abnormal group.
BMI, waist circumference and HOMA-IR were significant univariate predictors of being MENO in both men and women (Table 3) In multivariable analysis in men, when the effect of BMI was adjusted for, pack-years of cigarettes smoked (OR for pack-years of cigarettes smoked ¼ 0.97, 95% CI 0.94-0.99) and level of physical activity (OR for low vs high level of activity ¼ 0.16, 95% CI 0.05-0.52) remained independent predictors of being MENO. In women, the associations between waist circumference and HOMA-IR and metabolic status were not independent of BMI (OR 0.98, 95% CI 0.92-1.05, P ¼ 0.57 and OR 0.71, 95% CI 0.45-1.11, P ¼ 0.14, respectively).
BMI was significantly correlated with HOMA-IR (r ¼ 0.41, Po0.001 for both men and women), waist-to-hip ratio Metabolically normal overweight adults L Hayes et al (r ¼ 0.83 men, r ¼ 0.82 women, Po0.001 both) and waist circumference (r ¼ 0.35 men, r ¼ 0.27 women, Po0.001 both). HOMA-IR was significantly correlated with waist circumference and waist-to-hip ratio. These variables were more strongly correlated in men than in women (waist: r ¼ 0.59 men, r ¼ 0.38 women, Po0.001; waist-to-hip ratio: r ¼ 0.41 men, r ¼ 0.25 women, Po0.001).
Discussion
Overweight and obesity were common in men and women who participated in this study. Of those who were classified as overweight or obese, a substantial minority were 'metabolically normal' according to our definition. As expected, in men, lower BMI, waist circumference, waist-to-hip ratio and Metabolically normal overweight adults L Hayes et al HOMA-estimated insulin resistance were associated with being MENO in univariate analyses. Higher physical activity level and lower lifetime cigarette consumption also predicted being MENO, although only BMI, physical activity level and cigarette smoking were independent predictors. In women, only lower BMI was an independent significant predictor of being metabolically normal at the age of 50 years. The relationship between BMI and MENO status in women was weaker than in men suggesting that the association between general level of obesity and the likelihood of overweight and obese individuals developing metabolic abnormalities varies by gender. Body fat distribution may partly explain this apparent gender difference. There is a large body of existing work on the importance of body fat distribution, its association with insulin resistance and its role in the development of metabolic syndrome and Catch-up growth was calculated as the difference in z-scores of weight at birth and aged 9 years. Odds ratio given for a 0.1 increase in waist-hip ratio.
Metabolically normal overweight adults L Hayes et al cardiovascular disease. Abdominal obesity is known to be an important factor in determining insulin resistance and an adverse lipid profile. [18] [19] [20] There is evidence that intraabdominal fat, in particular, is associated with insulin resistance. 21 The women in this study were mainly perimenopausal; only a small number had early menopause. We were unable to examine the impact of menopausal status in this study. However, it is possible that the gender difference seen in this study was influenced by hormonal factors, and at least in part, their effect on body fat distribution. It was surprising that neither our measure of abdominal obesity (waist-to-hip ratio) nor HOMA-IR were independently associated with MENO status. In this study, HOMA-IR, waist-to-hip ratio and BMI were highly correlated. It is possible therefore that BMI masked the relationship between insulin resistance, abdominal obesity and metabolic status.
We did not find any evidence for the role played by early life experiences in future development of metabolic abnormalities in these data, nor did we find evidence of an interaction between birth weight and later BMI. This supports previous findings of a lack of an association between, in particular, birth weight and future cardiovascular disease and metabolic syndrome risk, in the Thousand Families cohort. 11, 12 However, experiencing childhood in a post-war environment, including the rationing of food, may have resulted in reduced variability in dietary disadvantage and less severe material disadvantage than cohorts born in the pre-war period. It is also possible that different results may have been obtained had other measures of fetal growth, such as ponderal index, been available to this investigation. No association was seen for dietary saturated fat intake. A previous investigation using data from this cohort suggested that the dietary questionnaire may have resulted in the under-reporting of dietary energy intake. 11 Other studies have conversely noted an over-reporting of energy intake, 22, 23 suggesting that results concerning dietary intake should be viewed with caution. Further, it is likely that crosssectional measures of dietary intake would not be the most appropriate when investigating metabolic factors in an overweight or obese population. Historical data on diet were not available to this investigation. Cigarette smoking was an independent predictor of being MENO in men. Retrospective data were used to estimate lifetime smoking history, which may be prone to bias, rather than using current smoking status which cannot distinguish between light and heavy smokers. However, our findings for smoking are consistent with previous research, which has found that smokers have higher fasting glucose and triglyceride levels than non-smokers 24 and that this relationship is more marked in men than in women. 25 The relationship between physical activity and MENO status in men is consistent with the hypothesis that insulin resistance is, at least partly, mediated by physical activity. 26 No effect was seen in women, however, with a nonsignificantly decreased chance of being normal in those women reporting the highest levels of activity. This is based on small numbers and may represent a spurious finding, although it is possible that some of the women who had a lipid, glucose or blood pressure abnormality had been prompted to increase their activity levels in an attempt to improve their health. More likely perhaps is that, as with using cross-sectional measures of diet in an overweight population, cross-sectional measures of activity may also be prone to bias. Retrospective data on physical activity were not collected for this study. Cross-sectional measures of BMI may also be affected by lifestyle changes that occur due to the metabolic abnormality and may bias risk estimates.
Conclusion
Over two-thirds of men and over half of women in this cohort were overweight or obese. However, a significant proportion of these individuals remain 'metabolically normal' suggesting that other factors must also play a role. Further research is required to identify both the factors involved and the individuals at a higher risk. Our findings suggest that lifestyle changes in an overweight and obese population, particularly when aimed at reducing the level of overweight or obesity, encouraging smoking cessation and increasing physical activity levels may reduce the incidence of metabolic abnormalities. With increasing rates of obesity at younger ages in the developed world, policies to reduce obesity at all ages may have far reaching effects on health in middle age and beyond.
